| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/27/2006 | US7067503 17-aryl linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase |
| 06/27/2006 | US7067484 AL-1 neurotrophic factor treatments |
| 06/27/2006 | US7067480 Compositions and methods of use for anti-inflammatory agents |
| 06/27/2006 | US7067474 A peptide or polypeptide obtained from the armadillo domain of human beta -catenin polypeptide which inhibits the interaction of human beta -catenin polypeptide and a transcription factor or tumor suppressor protein |
| 06/27/2006 | US7067296 Enzymatic polypeptide for use in the treatment of pain, inflammation, arthritis, cancer and alzheimer's disease |
| 06/27/2006 | US7067285 Desaturase genes and uses thereof |
| 06/27/2006 | US7067131 Methods for using anti-MUC18 antibodies |
| 06/27/2006 | US7067128 Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype |
| 06/27/2006 | US7067126 Synthase enzymes having chemokine, angiogenic or angiostsatic activity, used for medical diagnosis and prognosis |
| 06/27/2006 | US7067109 Cancer treatment kits comprising therapeutic conjugates that bind to aminophospholipids |
| 06/27/2006 | CA2326710C New dihydrofuro-¬3,4-b|quinolein-1-ones derivatives, the procedure for preparing them and the pharmaceutical compositions that contain them |
| 06/22/2006 | WO2006066183A2 Novel saframycin analogs as therapeutic agents |
| 06/22/2006 | WO2006065946A1 Pyrid-2-ones useful as inhibitors of tec family protein kinases for the treatment of inflammatory, proliferative and immunologically-mediated diseases |
| 06/22/2006 | WO2006065828A2 Novel farnesyl protein transferase inhibitors and their use to treat cancer |
| 06/22/2006 | WO2006065794A1 Farnesyl protein transferase inhibitors and methods for treating proliferative diseases |
| 06/22/2006 | WO2006065780A2 Combinations of therapeutic agents for treating cancer |
| 06/22/2006 | WO2006065703A1 Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as raf kinase inhibitors |
| 06/22/2006 | WO2006065686A2 Spiro derivatives as lipoxygenase inhibitors |
| 06/22/2006 | WO2006065480A2 Tetrahydrocarbazoles as active agents for inhibiting vegf production by translational control |
| 06/22/2006 | WO2006065479A2 Substituted phenols as active agents inhibiting vegf production |
| 06/22/2006 | WO2006065216A1 Novel hydantoin derivatives as metalloproteinase inhibitors |
| 06/22/2006 | WO2006065215A1 Novel compounds |
| 06/22/2006 | WO2006064944A1 Substituted pyrrole derivative |
| 06/22/2006 | WO2006064886A1 Agent for regulating bone formation |
| 06/22/2006 | WO2006064861A1 Function inhibitor of adam10 or adam17 protein and method of screening the same |
| 06/22/2006 | WO2006064790A1 Apoptosis inducer for cancer cells, metastasis inhibitor for cancer cells, anticancer agent, food product, anti-hiv agent and food product having anti-hiv effect |
| 06/22/2006 | WO2006064375A2 Aminoaryl substituted five-membered ring heterocyclic compounds for the treatment of diseases |
| 06/22/2006 | WO2006064291A1 Topical formulations for use in the treatment of prevention of skin cancers |
| 06/22/2006 | WO2006064277A1 Silicon compounds and their use |
| 06/22/2006 | WO2006064263A1 Silicon compounds and their use |
| 06/22/2006 | WO2006064251A1 4- (4- (imidazol-4-yl) pyrimidin-2-ylamino) benzamides as cdk inhibitors |
| 06/22/2006 | WO2006064246A1 N- (2-aminophenyl) -4- (5- ((ethylamino) methyl) 1,3-thiazol-2-yl) benzamide and n- (2-aminopheynl) -4- (5- ((isopropylamino) methyl) -1,3-thiazol-2-yl) benzamide as hdac inhibitors |
| 06/22/2006 | WO2006064196A1 Pyrazolopyrimidine compounds as antitumor agents |
| 06/22/2006 | WO2006064121A2 Cytotoxic antibody directed against type b lymphoid hematopoietic proliferations |
| 06/22/2006 | WO2006064044A1 Indolinones and their use as antiproliferative agents |
| 06/22/2006 | WO2006063805A1 3-amino-pyrazolo[3,4b]pyridines used as inhibitors of protein tyrosine kinases for treating angiogenic, hyperproliferative or neurodegenerative diseases |
| 06/22/2006 | WO2006063762A1 Dipeptide nitriles |
| 06/22/2006 | WO2006063707A2 Novel pharmaceutical composition containing at least one dolastatin 10 derivative |
| 06/22/2006 | WO2006063585A1 Triazole substituted aminobenzophenone compounds |
| 06/22/2006 | WO2006063506A1 Utilization for carbon nanosphere in anti-cancer medicine |
| 06/22/2006 | WO2006063402A1 Therapeutic compositions based on extracts of plants from the genus plumeria (frangipani) |
| 06/22/2006 | WO2006063382A1 Treatment of solid cancers |
| 06/22/2006 | WO2006044869A8 Synthesis of imidazooxazole and imidazothiazole inhibitors of p38 map kinase |
| 06/22/2006 | WO2006040047A3 Diagnostics and therapeutics for diseases associated with rho/rac-interacting citron kinase (cit) |
| 06/22/2006 | WO2006034832A3 Use of igfbp-2 in senescence diseases and for the maintenance of organ functions |
| 06/22/2006 | WO2006032525B1 Combinational therapy for treating cancer |
| 06/22/2006 | WO2006027701A3 Fas associated factor 1 |
| 06/22/2006 | WO2006026380A3 Geranylgeranyl pyrophosphate synthase inhibitors |
| 06/22/2006 | WO2006024488A3 Medical stent provided with inhibitors of atp synthesis |
| 06/22/2006 | WO2006016247A3 Lysis/resealing process and device for incorporating an active ingredient in erythrocytes |
| 06/22/2006 | WO2006008008A3 Diagnostics and therapeutics for diseases associated with hepatocyte nuclear factor 4, alpha (hnf4a) |
| 06/22/2006 | WO2005105213A3 Indole and azaindole derivatives with antitumor action |
| 06/22/2006 | WO2005101004A8 Diagnostics and therapeutics for diseases associated with purinoceptor 1 type y (p2y1) |
| 06/22/2006 | WO2004052276A3 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 06/22/2006 | US20060135842 Radiotherapy |
| 06/22/2006 | US20060135812 Thiol-based NAALADase inhibitors |
| 06/22/2006 | US20060135769 Farnesyl transferase inhibiting 4-heterocyclyl-quinoline and quinazoline derivatives |
| 06/22/2006 | US20060135749 Cd47 partal peptdie and anti-shps-1 monoclonal antibody |
| 06/22/2006 | US20060135618 Medicine comprising a thiourea for use as depigmenting agent or anti-mutagenic and anti-carcinogenic agent |
| 06/22/2006 | US20060135614 Novel compounds |
| 06/22/2006 | US20060135590 Selected fused pyrrolocarbazoles |
| 06/22/2006 | US20060135589 1h-Indazole-3-carboxamide compounds as cyclin dependent kinase (cdk) inhibitors |
| 06/22/2006 | US20060135583 e.g. 4-[3'-(3''-aminosulfonylpropyl)-4',4'-dimethyl-5'-oxo-2'-thioxo-1'-imidazolidinyl]-2-trifluoromethylbenzonitrile; anti-androgen agent which has a sufficient antagonistic effect and reduced side effect profile |
| 06/22/2006 | US20060135576 2-Amino-(imidazole, thiazole, or oxazole) derivatives; tyrosine kinase, endothelial growth factor, angiogenesis and fibroblast growth factor inhibitors; anticarcinogenic and antidiabetic agents |
| 06/22/2006 | US20060135573 Benzothiazole-4,7-diones and benzoxazole-4,7-diones with substituents in position 5 or 6 and method for production thereof |
| 06/22/2006 | US20060135572 Compounds as for example, 2'-[1-[(2R)-3-[[1-(3-fluoro-4-methylphenyl)-2-methylpropan-2-yl]amino]-2-hydroxypropoxy]ethyl]-3-methylbiphenyl-4-carboxylic acid, having a calcium-sensing receptor antagonistic action; therapeutic drug for osteoporosis |
| 06/22/2006 | US20060135545 derivatives of acronycine such as cis-2-cinnamoyloxy-1-hydroxy-6-methoxy-3,3,14-trimethyl-1,2,3,14-tetrahydro-1H-benzo[b]pyrano[3,2-h]acridin-7-one, used as antitumor agents |
| 06/22/2006 | US20060135534 Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 06/22/2006 | US20060135527 Use of imatinib (glivec,sti-571) to inhibit breast cancer resistance protein (bcrp)-mediated resistance to therapeutic agents |
| 06/22/2006 | US20060135516 3-(Carbonyl) 1h-indazole compounds as cyclin dependent kinases (cdk) inhibitors |
| 06/22/2006 | US20060135513 Methods of treating tumors |
| 06/22/2006 | US20060135508 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 06/22/2006 | US20060135501 Piperidinyl-thiazole carboxylic acid derivatives as angiogenesis inhibitors |
| 06/22/2006 | US20060135493 Use of 2-methylene-19-nor-20(S)-1alpha,25-dihydroxyvitamin D3 to increase bone strength |
| 06/22/2006 | US20060135492 Use of 2-methylene-19-nor-20(S)-1alpha,25-dihydroxyvitamin D3 to increase bone strength |
| 06/22/2006 | US20060135454 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 06/22/2006 | US20060135445 Breast cancer-resistant protein inhibitor |
| 06/22/2006 | US20060135431 Peptides and related molecules that bind to TALL-1 |
| 06/22/2006 | US20060135413 Depsipeptide for therapy of kidney cancer |
| 06/22/2006 | US20060134791 Masked targeted expression cassette which expresses a gene product only in the presence of target molecule; neoplasm |
| 06/22/2006 | US20060134782 Differentiated cells suitable for human therapy |
| 06/22/2006 | US20060134778 Method of treating a malignancy in a subject via direct picornaviral-mediated oncolysis |
| 06/22/2006 | US20060134767 Mitotic kinesin binding site |
| 06/22/2006 | US20060134764 Gene cluster involved in safracin biosynthesis and its uses for genetic engineering |
| 06/22/2006 | US20060134688 Genes overexpressed in prostate disorders as diagnostic and therapeutic targets |
| 06/22/2006 | US20060134668 Methods for treating patients and identifying therapeutics |
| 06/22/2006 | US20060134220 Vectorization system comprising nanoparticles of homogenous size of at least one polymer and at least one positively charged polysaccharide and method for the preparation thereof |
| 06/22/2006 | US20060134184 At least partially degradable films containing an active ingredient and method for the production of composition comprising an active compound |
| 06/22/2006 | US20060134140 Compositions and methods for treating tumor spreading |
| 06/22/2006 | US20060134136 Whole bacterial cells as immune modulator |
| 06/22/2006 | US20060134128 Screening for an inhibitor of binding between human Toll-like receptor 3 and a protein of specific amino acid sequence by contacting a candidate with a transfected cell encoding the protein which expresses the receptor; increased interferon in vivo; antitumor, autoimmune agents; side effect reduction |
| 06/22/2006 | US20060134119 Drugs containing galectin 9 |
| 06/22/2006 | US20060134118 using a monoclonal antibody or an antigen-binding portion which binds to an epitope of EphB4 polypeptide and inhibiting the growth of cancer as a result of such binding by causing cell death |
| 06/22/2006 | US20060134117 Preventives/remedies for cancer |
| 06/22/2006 | US20060134116 Ca 125 tumor antigen function and uses thereof |
| 06/22/2006 | US20060134115 Method of screening for sensitivity to kinase inhibitor therapy |
| 06/22/2006 | US20060134090 Method and dietary composition for improving lipid digestibility |
| 06/22/2006 | US20060134085 Compositions containing coenzyme q10 |
| 06/22/2006 | US20060133994 Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis |
| 06/22/2006 | CA2675642A1 Process for the preparation of 4-(6-chloro-2,3-methylenedioxyanilino)-7-[2-(4-methyl piperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxyquinazoline, their intermediates and crystalline salts thereof |